Runpu Bio
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Runpu Bio - overview
Established
2010
Location
-, -, -
Primary Industry
Biotechnology
About
Based in Shanghai, China, and founded in 2010, Shanghai Runpu Biotechnology Co. , Ltd. , trading as Runpo Bio, is a high-tech enterprise dedicated to the R&D, production, and sales of in vitro diagnostic (IVD) reagents—specifically those used in clinical testing, blood transfusion, and blood-type tissue matching. In 2017, Med Captain, a portfolio company of Shenzhen Capital Real Estate Fund, Shenzhen Guozhong Venture Capit, acquired 100% stake in Runpo Bio.
The company’s main products include fully automated blood-typing analyzers, micro-column gel blood-typing cards, and transfusion-related testing reagents. Runpu Bio aims to be a professional supplier and service provider of IVD reagents and testing instruments, delivering precision blood transfusion solutions to clinical testing institutions. The company’s revenue is generated by providing biotechnology service and in vitro diagnostic (IVD) reagents.
Current Investors
Med Captain
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Medical Devices & Equipment, Pharmaceuticals
Verticals
HealthTech, Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Runpu Bio - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Runpu Bio | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.